These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9708526)

  • 1. Salivary function in patients with reflux esophagitis: effect of cisapride.
    Chen SD; Kao CH; Chang CS; Chen GH
    J Nucl Med; 1998 Aug; 39(8):1449-52. PubMed ID: 9708526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for decreased salivary function in patients with reflux esophagitis.
    Kao CH; Ho YJ; ChangLai SP; Liao KK
    Digestion; 1999; 60(3):191-5. PubMed ID: 10343131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cisapride on salivary production in normal subjects.
    Patel R; Launspach J; Soffer E
    Dig Dis Sci; 1996 Mar; 41(3):480-4. PubMed ID: 8617119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study.
    Paterson WG; Wang H; Beck IT
    Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease.
    Holloway RH; Penagini R; Schoeman MN; Dent J
    Am J Gastroenterol; 1999 Mar; 94(3):799-803. PubMed ID: 10086669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland scintigraphy in gastro-esophageal reflux disease.
    Urita Y; Domon K; Yanagisawa T; Ishihara S; Hoshina M; Akimoto T; Kato H; Hara N; Honda Y; Nagai Y; Nakanishi K; Shimada N; Takano M; Watanabe T; Sugimoto M; Miki K
    Inflammopharmacology; 2007 Aug; 15(4):141-5. PubMed ID: 17701015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride and cimetidine in the treatment of erosive esophagitis.
    Maleev A; Mendizova A; Popov P; Vlahov V; Dimitrov B; Mihova A; Crowe J; Silveira J; Thomson A; Routhier G
    Hepatogastroenterology; 1990 Aug; 37(4):403-7. PubMed ID: 2210608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythromycin on postprandial gastroesophageal reflux in reflux esophagitis.
    Pehl C; Pfeiffer A; Wendl B; Stellwag B; Kaess H
    Dis Esophagus; 1997 Jan; 10(1):34-7. PubMed ID: 9079271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid reflux test for gastroesophageal reflux after distal gastrectomy: diagnosis and clinical effect of cisapride.
    Shibata Y; Nimura Y; Toyoda S; Yasui A; Kawamura T
    J Am Coll Surg; 1998 May; 186(5):596-600. PubMed ID: 9583703
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
    Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
    Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Sekiguchi T; Nishioka T; Matsuzaki T; Sugiyama M; Kusano M; Horikoshi T; Toki M; Ohwada T; Kobayashi S
    Gastroenterol Jpn; 1991 Apr; 26(2):137-44. PubMed ID: 2040397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
    Galmiche JP; Fraitag B; Filoche B; Evreux M; Vitaux J; Zeitoun P; Fournet J; Soule JC
    Dig Dis Sci; 1990 May; 35(5):649-55. PubMed ID: 2331957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased salivary gland function in patients with autoimmune thyroiditis.
    Chang CP; Shiau YC; Wang JJ; Ho ST; Kao CH
    Head Neck; 2003 Feb; 25(2):132-7. PubMed ID: 12509796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propulsid (cisapride).
    Claussen DW
    Gastroenterol Nurs; 1994 Apr; 16(5):235-6. PubMed ID: 8193188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.